Live Breaking News & Updates on Howard Federoff

Stay updated with breaking news from Howard federoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kenai Therapeutics Raises $82M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , San Diego , Howard Federoff , Ryne Bio , Jeffrey Kordower , Column Group , Alaska Permanent Fund Corporation , Kenai Therapeutics , Cure Ventures , Euclidean Capital ,

Kenai Therapeutics Announces 82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures. ....

United States , San Diego , San Francisco , Jeff Goater , Jeff Jonas , Tomoyuki Hasegawa , Jeffrey Kordower , Ryne Bio , Nick Manusos , Howard Federoff , Column Group , Alaska Legislature , Alaska Permanent Fund Corporation , Cellular Dynamics Inc , Alaska Permanent Fund , Cure Ventures , Euclidean Capital , Saisei Ventures , Kenai Therapeutics , Nobel Prize Winning , Alaska Permanent , Media Contact ,

Ryne Biotechnology receives CIRM grant to advance RNDP-001

Ryne Biotechnology has received a $4m CLIN1 grant from the California Institute for Regenerative Medicine (CIRM) to advance its lead candidate RNDP-001. ....

Ryne Bio , Howard Federoff , Nick Manusos , Ryne Biotechnology ,